Studying pneumolysin presents several challenges. Its complex interactions with host cells and the immune system require advanced techniques for analysis. Additionally, the variability among pneumococcal strains can affect the efficacy of potential treatments. Overcoming these challenges involves interdisciplinary research and the development of innovative models to simulate human infections.
